{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:35:45Z","timestamp":1778877345600,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"DOI":"10.1038\/emm.2016.58","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T07:07:03Z","timestamp":1469776023000},"page":"e249-e249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sur8 mediates tumorigenesis and metastasis in colorectal cancer"],"prefix":"10.1038","volume":"48","author":[{"given":"Young-Mi","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saluja","family":"Kaduwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kug Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Jeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Yell","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"BFemm201658_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1200\/JCO.2005.08.097","volume":"23","author":"ET Hawk","year":"2005","unstructured":"Hawk ET, Levin B . Colorectal cancer prevention. J Clin Oncol 2005; 23: 378\u2013391.","journal-title":"J Clin Oncol"},{"key":"BFemm201658_CR2","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1038\/onc.2010.89","volume":"29","author":"A Lievre","year":"2010","unstructured":"Lievre A, Blons H, Laurent-Puig P . Oncogenic mutations as predictive factors in colorectal cancer. Oncogene 2010; 29: 3033\u20133043.","journal-title":"Oncogene"},{"key":"BFemm201658_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/187152012799014968","volume":"12","author":"T Yokota","year":"2012","unstructured":"Yokota T . Are KRAS\/BRAF mutations potent prognostic and\/or predictive biomarkers in colorectal cancers? Anticancer Agents Med Chem 2012; 12: 163\u2013171.","journal-title":"Anticancer Agents Med Chem"},{"key":"BFemm201658_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/327293a0","volume":"327","author":"JL Bos","year":"1987","unstructured":"Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293\u2013297.","journal-title":"Nature"},{"key":"BFemm201658_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/carcin\/bgg009","volume":"24","author":"M Brink","year":"2003","unstructured":"Brink M, de Goeij AF, Weijenberg MP, Roemen GM, Lentjes MH, Pachen MM et al. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 2003; 24: 703\u2013710.","journal-title":"Carcinogenesis"},{"key":"BFemm201658_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fonc.2014.00035","volume":"4","author":"G Cathomas","year":"2014","unstructured":"Cathomas G . PIK3CA in Colorectal Cancer. Front Oncol 2014; 4: 35.","journal-title":"Front Oncol"},{"key":"BFemm201658_CR7","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.3748\/wjg.v13.i28.3806","volume":"13","author":"K Field","year":"2007","unstructured":"Field K, Lipton L . Metastatic colorectal cancer-past, progress and future. World J Gastroenterol 2007; 13: 3806\u20133815.","journal-title":"World J Gastroenterol"},{"key":"BFemm201658_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/joim.12070","volume":"274","author":"A Silvestri","year":"2013","unstructured":"Silvestri A, Pin E, Huijbers A, Pellicani R, Parasido EM, Pierobon M et al. Individualized therapy for metastatic colorectal cancer. J Intern Med 2013; 274: 1\u201324.","journal-title":"J Intern Med"},{"key":"BFemm201658_CR9","first-page":"193","volume":"386","author":"K Giehl","year":"2005","unstructured":"Giehl K . Oncogenic Ras in tumour progression and metastasis. Biol Chem 2005; 386: 193\u2013205.","journal-title":"Biol Chem"},{"key":"BFemm201658_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc3106","volume":"11","author":"Y Pylayeva-Gupta","year":"2011","unstructured":"Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D . RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 2011; 11: 761\u2013774.","journal-title":"Nat Rev Cancer"},{"key":"BFemm201658_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P et al. Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 2011; 3: 192\u2013222.","journal-title":"Aging"},{"key":"BFemm201658_CR12","doi-asserted-by":"publisher","first-page":"djt373","DOI":"10.1093\/jnci\/djt373","volume":"106","author":"BS Moon","year":"2014","unstructured":"Moon BS, Jeong WJ, Park J, Kim TI, Min do S, Choi KY . Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt\/beta-catenin signaling. J Natl Cancer Inst 2014; 106: djt373.","journal-title":"J Natl Cancer Inst"},{"key":"BFemm201658_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.cellbio.19.111401.091942","volume":"19","author":"DK Morrison","year":"2003","unstructured":"Morrison DK, Davis RJ . Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol 2003; 19: 91\u2013118.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFemm201658_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0092-8674(00)81227-1","volume":"94","author":"DS Sieburth","year":"1998","unstructured":"Sieburth DS, Sun Q, Han M . SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans. Cell 1998; 94: 119\u2013130.","journal-title":"Cell"},{"key":"BFemm201658_CR15","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.1073\/pnas.95.12.6903","volume":"95","author":"LM Selfors","year":"1998","unstructured":"Selfors LM, Schutzman JL, Borland CZ, Stern MJ . soc-2 encodes a leucine-rich repeat protein implicated in fibroblast growth factor receptor signaling. Proc Natl Acad Sci USA 1998; 95: 6903\u20136908.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm201658_CR16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1101\/gad.14.8.895","volume":"14","author":"W Li","year":"2000","unstructured":"Li W, Han M, Guan KL . The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf. Genes Dev 2000; 14: 895\u2013900.","journal-title":"Genes Dev"},{"key":"BFemm201658_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.molcel.2006.03.027","volume":"22","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F . A phosphatase holoenzyme comprised of Shoc2\/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell 2006; 22: 217\u2013230.","journal-title":"Mol Cell"},{"key":"BFemm201658_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.molcel.2013.10.004","volume":"52","author":"LC Young","year":"2013","unstructured":"Young LC, Hartig N, Munoz-Alegre M, Oses-Prieto JA, Durdu S, Bender S et al. An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth. Mol Cell 2013; 52: 679\u2013692.","journal-title":"Mol Cell"},{"key":"BFemm201658_CR19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.425","volume":"41","author":"V Cordeddu","year":"2009","unstructured":"Cordeddu V, Di Schiavi E, Pennacchio LA, Ma'ayan A, Sarkozy A, Fodale V et al. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet 2009; 41: 1022\u20131026.","journal-title":"Nat Genet"},{"key":"BFemm201658_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/ajmg.a.35318","volume":"158A","author":"R Hoban","year":"2012","unstructured":"Hoban R, Roberts AE, Demmer L, Jethva R, Shephard B . Noonan syndrome due to a SHOC2 mutation presenting with fetal distress and fatal hypertrophic cardiomyopathy in a premature infant. Am J Med Genet A 2012; 158A: 1411\u20131413.","journal-title":"Am J Med Genet A"},{"key":"BFemm201658_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/jhg.2010.116","volume":"55","author":"S Komatsuzaki","year":"2010","unstructured":"Komatsuzaki S, Aoki Y, Niihori T, Okamoto N, Hennekam RC, Hopman S et al. Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies. J Hum Genet 2010; 55: 801\u2013809.","journal-title":"J Hum Genet"},{"key":"BFemm201658_CR22","doi-asserted-by":"publisher","first-page":"33091","DOI":"10.18632\/oncotarget.5173","volume":"6","author":"S Kaduwal","year":"2015","unstructured":"Kaduwal S, Jeong WJ, Park JC, Lee KH, Lee YM, Jeon SH et al. Sur8\/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling. Oncotarget 2015; 6: 33091\u201333105.","journal-title":"Oncotarget"},{"key":"BFemm201658_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1083\/jcb.147.5.1009","volume":"147","author":"EE Sander","year":"1999","unstructured":"Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG . Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 1999; 147: 1009\u20131022.","journal-title":"J Cell Biol"},{"key":"BFemm201658_CR24","doi-asserted-by":"publisher","first-page":"ra30","DOI":"10.1126\/scisignal.2002242","volume":"5","author":"WJ Jeong","year":"2012","unstructured":"Jeong WJ, Yoon J, Park JC, Lee SH, Lee SH, Kaduwal S et al. Ras stabilization through aberrant activation of Wnt\/beta-catenin signaling promotes intestinal tumorigenesis. Sci Signal 2012; 5: ra30.","journal-title":"Sci Signal"},{"key":"BFemm201658_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/stem.586","volume":"29","author":"BS Moon","year":"2011","unstructured":"Moon BS, Kim HY, Kim MY, Yang DH, Lee JM, Cho KW et al. Sur8\/Shoc2 involves both inhibition of differentiation and maintenance of self-renewal of neural progenitor cells via modulation of extracellular signal-regulated kinase signaling. Stem Cells 2011; 29: 320\u2013331.","journal-title":"Stem Cells"},{"key":"BFemm201658_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1535-6108(03)00088-6","volume":"3","author":"JJ Zhao","year":"2003","unstructured":"Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM et al. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 2003; 3: 483\u2013495.","journal-title":"Cancer Cell"},{"key":"BFemm201658_CR27","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","volume":"66","author":"A Lievre","year":"2006","unstructured":"Lievre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 2006; 66: 3992\u20133995.","journal-title":"Cancer Res"},{"key":"BFemm201658_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/1097-0142(19890201)63:3<604::AID-CNCR2820630334>3.0.CO;2-2","volume":"63","author":"RR Love","year":"1989","unstructured":"Love RR, Leventhal H, Easterling DV, Nerenz DR . Side effects and emotional distress during cancer chemotherapy. Cancer 1989; 63: 604\u2013612.","journal-title":"Cancer"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/emm201658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm201658","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm201658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:23:14Z","timestamp":1672820594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm201658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7]]}},"alternative-id":["BFemm201658"],"URL":"https:\/\/doi.org\/10.1038\/emm.2016.58","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]},"assertion":[{"value":"23 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}